Robert W. Scully - 06 Feb 2024 Form 4 Insider Report for Zoetis Inc. (ZTS)

SEC evidence 5 facts
Form type
4
Accepted by SEC
08 Feb 2024, 16:34:42 UTC
Previous filing
14 Dec 2023
Next filing
12 Feb 2024
SEC filing
View on sec.gov
Reporting owner 1 fact
Reporting owner signature
/s/ Lauren Luptak, as Attorney-in-Fact

Key filing fact

Robert W. Scully filed Form 4 for Zoetis Inc. (ZTS) on 08 Feb 2024.

Key facts

  • This page summarizes Robert W. Scully's Form 4 filing for Zoetis Inc. (ZTS).
  • 1 reported transaction and 3 derivative rows are listed below.
  • Accepted by SEC: 08 Feb 2024, 16:34.

Change

  • Previous filing in this sequence was filed on 14 Dec 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ZTS transaction Derivative

Restricted Stock Unit

Award

Transaction value
$0
Shares
+1,223
Change %
Price
$0.000000
Shares after
1,223
Date
06 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,223
Exercise price
Footnotes
F1, F2, F3, F4
ZTS holding Derivative

Restricted Stock Unit

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,493
Date
06 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,493
Exercise price
Footnotes
F1, F2, F4, F5
ZTS holding Derivative

Restricted Stock Unit

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,676
Date
06 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,676
Exercise price
Footnotes
F2, F4, F6, F7, F8
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 8 footnotes

Footnote F1

Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs").

Footnote F2

Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock.

Footnote F3

Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first anniversary of the date of grant, February 6, 2024; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

Footnote F4

Not applicable.

Footnote F5

Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first anniversary of the date of grant, February 8, 2023; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

Footnote F6

Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs").

Footnote F7

Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

Footnote F8

The RSUs vest as follows: 1,463.3937 RSUs will vest on February 10, 2024; and 1,212.3053 RSUs will vest on February 8, 2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .